Press Releases
June 14, 2023
PredxBio Appoints Dr. Stanley Marks, Chairman of UPMC Hillman Cancer Center, to its Board of Directors, Strengthening Expertise in Oncology and Precision Medicine
PredxBio, the industry leader in Spatial Biology and Explainable AI for predicting disease progression, is pleased to announce the addition of Dr. Stanley Marks, Chairman of UPMC Hillman Cancer Center, to its Board of Directors.
June 7, 2023
PredxBio Strengthens Leadership Team with Appointment of Brad Spitz as Chief Commercial Officer
PredxBio, the leading company in Spatial Biology and Explainable AI for predicting the progression of disease has announced the appointment of Brad Spitz, MBA, as its Chief Commercial Officer. In this role, Brad will drive the company’s commercial growth strategy, lead global sales and business development efforts, and further expand PredxBio’s presence in the biopharma industry.
April 17, 2023
PredxBio is bending the survival curve for immunotherapy cancer patients with spatially intelligent biology at AACR 2023
PredxBio (formerly SpIntellx) announces that it will attend the 2023 Annual Meeting of American Association for Cancer Research in Orlando, April 15-19, Booth #974 and Poster #5445 to present their explainable AI-powered unbiased spatial analytics platform, that seamlessly integrates multimodal data to unravel the hidden circuitries of the tumor microenvironment and reveal the complex network biology of the cancer…
April 4, 2023
SpIntellx Rebrands as PredxBio to Unlock Spatial Biology Insights with Explainable AI
SpIntellx, the leader in Spatial Biology leveraging Explainable AI for predicting the progression of disease, announced today its rebranding as PredxBio (pronounced, “pre-dix-bio”). The PredxBio platform is designed to empower drug discovery, translation, and clinical trials, initially focusing on immuno-oncology space…
August 18, 2022
PredxBio and iCura Diagnostics Partner to Expand Access to Advanced Spatial Analytics and Explainable AI Products for Pathology and Oncology Research
PredxBio, Inc., a leader in spatially intelligent biology and iCura Diagnostics, a leading contract research organization focused on capitalizing multiomic data to accelerate end-to-end clinical workflow solutions and biomarker discovery, have announced a partnership to transform precision oncology through unlocking the power of genomic, proteomics, and transcriptomic data using advanced spatial analytics…
JULY 18, 2022
PredxBio and Inspirata Announce New Technical Partnership and Integration to Expand Access to Next Generation Explainable AI Software for Breast Biopsies
PredxBio, Inc., and Inspirata have announced that they will collaborate to integrate the PredxBio HistoMapr-Breast™ platform and Inspirata’s Dynamyx® software into one seamless solution. HistoMapr-Breast is the one and only computational pathology software that taps the power of explainable artificial intelligence (xAI) for healthcare providers to diagnose, prognosticate and treat breast cancer more efficiently and accurately…
MAY 16, 2022
PredxBio Appoints Industry Leader B. Dusty Majumdar, Ph.D. as Chief Executive Officer to Spearhead the Next Phase of Growth
B. Dusty Majumdar, Ph.D. has been appointed as the Chief Executive Officer (CEO) of PredxBio, Inc., a precision pathology company whose mission is focused on dramatically improving patient outcomes fueled by proprietary unbiased spatial analytics and explainable AI. Dr. Majumdar, is a seasoned leader in Precision Healthcare with more than 20 years of experience in building and successfully launching innovative technologies across diagnostic imaging, oncology, multi-omics,…
APRIL 05, 2022
PredxBio is ushering a new era of unbiased spatial analytics and explainable AI in precision pathology at AACR 2022
PredxBio, Inc. created the new era of precision pathology to dramatically improve patient outcomes by leveraging proprietary unbiased spatial analytics and explainable AI. PredxBio’s precision pathology solutions have the potential to unlock a plethora of new applications in medicine and research by answering the fundamental question “Why?” , thus revealing the underlying patient-specific disease network biology across each stage of the drug development, diagnostics, and treatment pipelines…
MARCH 18, 2022
PredxBio announces the new era of precision pathology at USCAP 2022
PredxBio, Inc. created the new era of precision pathology to dramatically improve patient outcomes by leveraging proprietary unbiased spatial analytics and explainable AI that answers the question “Why?” to reveal the underlying patient-specific disease network biology, across each stage of the drug development, diagnostic and treatment pipelines. PredxBio offers software as a service (SaaS) for precision pathology applications harnessing unbiased spatial analytics and explainable AI including: accelerated drug discovery for identifying novel targets, biomarkers and “invisible” cell types; optimized clinical trials for precision patient stratification;…
JUNE 14, 2021
Meet the 7 life science startups of AlphaLab Health’s inaugural accelerator cohort
Seven promising life science startups started off 2020 with a shot of support from two of the region’s health and economic development-minded orgs.
Launched in September 2020, AlphaLab Health is an initiative of Innovation Works, which also runs the AlphaLab and AlphaLab Gear accelerator programs, and Allegheny Health Network. Those selected for the program’s cohorts receive early-stage funding of up to $100,000, access to mentorship and clinical expertise through AlphaLab’s network,…
JULY 20, 2020
PredxBio and CellNetix Collaborate to Validate HistoMapr-Breast™, an Explainable AI Software Platform Featuring Advanced Spatial Analytics to Provide Intelligent Guides for Pathology Laboratories
PredxBio, Inc., and CellNetix Pathology & Laboratories have announced that they will collaborate to validate the PredxBio HistoMapr-Breast™ Platform, which taps the power of explainable artificial intelligence (xAI) for healthcare providers to diagnose and treat breast cancer more efficiently and accurately…
DECEMBER 17, 2019
Innovations in Artificial Intelligence, Cloud, Blockchain, and Analytics, 2019: Advances in AI, Blockchain, and Business Intelligence - ResearchAndMarkets.com
This edition of IT, Computing and Communications (ITCC) TechVision Opportunity Engine (TOE) provides a snapshot of the emerging ICT led innovations in artificial intelligence, machine learning, cloud, and analytics. This issue focuses on the application of information and communication technologies in alleviating the challenges faced across industry sectors in areas such as banking, oil & gas, healthcare, life sciences, and industrial sectors…
